-
Abstract: We reported a case of a 43-year-old female patient with nasal Sjogren's syndrome(SS). She complained of dry and tingling nose for 5 months. Physical examination: bilateral nasal stenosis, swelling of the mucosa at the front of the nasal septum, dry oral mucosa, and strawberry tongue. Sinus CT showed: bilateral nasal cavity stenosis, nasal septal mucosa and bilateral nasal mucosa hypertrophy. Salivary gland dynamic imaging: the maximum excretion percentage of the left salivary gland is 4.05%, and the maximum excretion percentage of the right salivary gland is 1.81%. Labial gland biopsy showed that the salivary gland lobular structure existed, and multiple lymphocyte foci(>50/each foci) were seen in the focal interstitium, which was consistent with the labial gland performance of SS. Immunohistochemistry showed: CD3+, CD20+, AE1/AE3+, Ki-67+, IgG+. After symptomatic treatment, the patient's dry nose and tingling symptoms disappeared. The swelling of the nasal mucosa disappeared, and the bilateral nasal cavity was well ventilated. Follow-up for half a year, no symptoms of nasal manifestations about Sjogren's syndrome has occurred.
-
Key words:
- Sjogren's syndrome /
- nose /
- clinical manifestations
-
-
[1] 金月波, 何菁. 2016年美国风湿病学会/欧洲抗风湿病联盟原发性干燥综合征分类标准[J]. 中华风湿病学杂志, 2017, 21(3): 213-213. doi: 10.3760/cma.j.issn.1007-7480.2017.03.018
[2] 陈小青, 林玲, 黄子扬, 等. 干燥综合征患者唇腺催乳素表达与局部免疫紊乱[J]. 中华内科杂志, 2006, 45(4): 323-324. doi: 10.3760/j.issn:0578-1426.2006.04.021
[3] Jin L, Yu D, Li X, et al. CD4+CXCR5+ follicular helper T cells in salivary gland promote B cells maturation in patients with primary Sjogren's syndrome[J]. Int J Clin Exp Pathol, 2014, 7(5): 1988-1996.
[4] Vivino FB. Sjogren's syndrome: Clinical aspects[J]. Clin Immunol, 2017, 182: 48-54. doi: 10.1016/j.clim.2017.04.005
[5] Ramos-Casals M, Tzioufas AG, Stone JH, et al. Treatment of primary Sjögren syndrome: a systematic review[J]. JAMA, 2010, 304(4): 452-460. doi: 10.1001/jama.2010.1014
[6] Vivino FB, Al-Hashimi I, Khan Z, et al. Pilocarpine tablets for the treatment of dry mouth and dry eye symptoms in patients with Sjögren syndrome: a randomized, placebo-controlled, fixed-dose, multicenter trial. P92-01 Study Group[J]. Arch Intern Med, 1999, 159(2): 174-181. doi: 10.1001/archinte.159.2.174
[7] Furness S, Worthington HV, Bryan G, et al. Interventions for the management of dry mouth: topical therapies[J]. Cochrane Database Syst Rev, 2011, (12): CD008934.
[8] Carsons SE, Vivino FB, Parke A, et al. Treatment Guidelines for Rheumatologic Manifestations of Sjögren's Syndrome: Use of Biologic Agents, Management of Fatigue, and Inflammatory Musculoskeletal Pain[J]. Arthritis Care Res(Hoboken), 2017, 69(4): 517-527. doi: 10.1002/acr.22968
[9] Stefanski AL, Tomiak C, Pleyer U, et al. The Diagnosis and Treatment of Sjögren's Syndrome[J]. Dtsch Arztebl Int, 2017, 114(20): 354-361.
-